Drug shortage: Azacitidine Injection (AZACITIDINE, VIDAZA)
FDA lists 9 presentations as Current. Availability: Unavailable (4), Limited Availability (1), Available (4). Reason: Other; Demand increase for the drug. Companies: Teva Pharmaceuticals USA, Inc., Eugia US LLC, Armas Pharmaceuticals Inc, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc.….
- Published by source
- 2020-12-18
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Products
- Azacitidine Injection AZACITIDINE VIDAZA
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: TBD
- On backorder. Recovery: TBD. Check wholesalers for inventory
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2020-12-18
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #866 | new | 2026-10-22 | 155cffabd466…cfbb84 | 1e5265ca9eed…dc426c |
Chain head: #1076 8ad5adc30b9b…88ce20